InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,238.00
(
-0.11%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.98
(
-0.04%
)
Bitcoin
64,209.46
(
-0.94%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 151369

Wednesday, 10/31/2012 5:23:36 AM

Wednesday, October 31, 2012 5:23:36 AM

Post# of 252279
Sounds like the beta amyloid biomarker results showed a trend in favor of Solanezumab but

There were no changes noted in other AD biomarkers such as tau, phosphorylated tau, hippocampal
volume, whole brain volume, or amyloid accumulation measured by PET imaging.

http://www.ctad.fr/07-download/Congres2012/PressRelease/Sola-Release_29Oct2012.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up